Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 10, 93-95, February 1, 1950]
© 1950 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feinstein, R. N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Feinstein, R. N.

Effects of a Growth Inhibitor and Other Factors on the Tissue Cathepsins of Tumor-bearing Rats*

Robert N. Feinstein, Ph.D.

(From the Toxicity Laboratory and the Department of Biochemistry, University of Chicago, Chicago)

1. The catheptic activity of rat spleen, liver, and tumor (Walker carcinoma 256) has been determined under the influence of a variety of treatments.
2. In confirmation of earlier work, it is shown that the presence of this tumor causes an increased catheptic activity in the host tissues.
3. Treatment of tumor-bearing animals with 4-dimethylaminostilbene hydrochloride, a potent tumor growth inhibitor, increases the catheptic activity of the tumor; it also decreases the catheptic activity of the spleen of the starved, tumor-bearing rat, and has a tendency, not mathematically significant, to decrease also the catheptic activity of the liver and spleen of the fed, tumor-bearing rat.
4. Starvation increases tumor catheptic activity.
5. Treatment of a starved animal with the stilbene compound further increases the tumor's catheptic activity.

* The work described in this paper was done under contract between the Medical Division, Chemical Corps, U.S. Army, and the University of Chicago Toxicity Laboratory. Under the terms of the contract the Chemical Corps neither restricts nor is responsible for the opinions or conclusions of the authors.

Received 9/15/49.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1950 by the American Association for Cancer Research.